Decreased Serum Mir-375 And Mir-320a Levels Are Useful In Predicting Liver Cancer

Xvbo Chen,Qingsong Fan,Wenjuan Gu,Long Yu

2019-01-01

Abstract:Purpose: The aim of the current study was to explore expression levels of miR-375 and miR-320a in the plasma of patients with liver cancer, analyzing diagnostic efficacy and the effects of miR-375 and miR-320a. Methods: Blood samples from 72 patients with liver cancer and blood samples from 46 concurrent health examinations were used for prospective analysis. Patients with liver cancer were defined as the liver cancer group, while healthy physical examination patients were defined as the control group. Real-time quantitative PCR (RT-PCR) was used to measure expression of miR-375 and miR-320a in plasma. Differences in expression levels of miR-375 and miR-320a between the liver cancer group and control group were determined. Correlation levels between miR-375 and miR-320a and liver cancer incidence rates were analyzed, as well as the value of miR-375 and miR-320a for diagnosis of liver cancer. Results: Expression levels of miR-375 and miR-320a in the liver cancer group were significantly lower than those in the control group (P<0.001). Expression levels of miR-375 and miR-320a showed no differences in different patients in terms of age, weight, sex, place of residence, smoking habits, and exercise habits (P>0.050). However, they showed significant differences in different pathological stages, lymphatic metastasis, and differentiation degrees (P<0.001). Receiver operating characteristic curve analysis indicated that, for miR-375 expression at a cut-off value of 15.28, the sensitivity for diagnosing liver cancer was 95.22%. The specificity was 61.94%. Using 16.68 as a cut-off value for miR-320a expression, the sensitivity for diagnosing liver cancer was 98.61% and the specificity was 58.94%. Using 0.507 as a cut-off value for miR-375 and miR-320a expression, the sensitivity for combined diagnosing liver cancer was 71.53% and the specificity was 89.75%. Conclusion: The combination of miR-375 and miR-320a may become a useful indicator for diagnosis of liver cancer in the future.